Vigmed wins first hospital tender

After announcing first sales to distributors in June, Vigmed AB has now won
their first hospital tender with Region Skåne in Sweden through their
distribution partner CODAN TRIPLUS AB. CODAN was awarded a contract up to four
years for the CLiP Neo I.V. Cannula. This patented product helps prevent
accidental needle stick injuries primarily within neonatal and paediatric care.
Sales of medical devices to hospitals in the European Union are strictly
regulated by tender directives. To successfully offer products within EU, it is
vital to understand the processes and have the necessary competencies before
entering a public call for tender.

 [image]

“This is the result of a successful partnership with CODAN TRIPLUS and a great
affirmation that our product and development procedures can deliver what we
promise. We are particularly pleased to announce that we have won our first
tender in our home market. This further strengthens our position and confirms
that we have the right platform, quality and positioning to continue to see
success in other European markets”, comments Vigmed Sales Director, Mike Dooley.

“We are very pleased to receive the contract approval from Region Skåne which
marks a first step on an exciting journey with Vigmed”, says CODAN CEO, Lennart
Bådersjö.

Vigmed AB, based in Helsingborg, Sweden, is currently launching several
innovation platforms in Europe while striving to eliminate needle stick
injuries.
For further information contact:

CEO, Finn Ketler +46 42 600 5311 or Sales Director Europe, Mike Dooley +46 42
600 5317
Vigmed is a Swedish medical technology company whose mission is to eliminate
needlestick injuries by offering the market unique needle-protected products.
Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20
employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm
(ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the
Company’s Certified Advisor.

Additional information such as company description, a video presentation and
risk factors can be found on Vigmed’s website: www.vigmed.com/investor